Corey Tsang, University of Ottawa

Research

Antimicrobial Resistance Biomarker C.Difficile Infection Chimeric Antigen Receptor T-Cell Therapy Feasibility Hematopoietic Stem Cell Transplantation Microbiome Pilot

Latest papers

Drug-drug interactions in anticoagulant therapy: a focus on oncology patients.
Expert review of clinical pharmacology · 2025
The utility of H2 receptor antagonists in preventing infusion-related reactions to paclitaxel chemotherapy.
Cancer · 2023 · first author
Pre-medication protocols for the prevention of paclitaxel-induced infusion related reactions: a systematic review and meta-analysis.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022 · senior author

All 7 publications

Latest funding

Oral Vancomycin for the Prevention of C. difficile Infection in High-Risk HCT and CAR-T Patients (VAPOR-HCT): A Pilot Randomized Placebo-Controlled Trial
CIHR · 2025 · Principal investigator
$100,000

All 1 grants and awards

7 publications.

01

Drug-drug interactions in anticoagulant therapy: a focus on oncology patients.

Vrotniakaite-Bajerciene K, Tsang C, Wang TF, Carrier M

Expert review of clinical pharmacology2025

DOI: 10.1080/17512433.2025.2585448 PMID: 41181919

02

The utility of H2 receptor antagonists in preventing infusion-related reactions to paclitaxel chemotherapy.

Tsang C, Robinson J, Wheatley-Price PF, Brule SY, Moore SM

Cancer2023First author

DOI: 10.1002/cncr.35006 PMID: 37665180

03

Pre-medication protocols for the prevention of paclitaxel-induced infusion related reactions: a systematic review and meta-analysis.

Dubinsky S, Patel D, Wang X, Srikanthan A, Ng TL, Tsang C

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2022Senior author

DOI: 10.1007/s00520-022-06891-0 PMID: 35150312

04

Accurate determination of glomerular filtration rate in adults for carboplatin dosing: Moving beyond Cockcroft and Gault.

Tsang C, Akbari A, Frechette D, Brown PA

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners2021First author

DOI: 10.1177/1078155220978446 PMID: 33297846

05

Impact on confidence and practice: How the ADAPT online patient care skills program made a difference for pharmacists.

Farrell B, Archibald D, Pizzola L, Ward N, Cho A, Tsang C

Research in social & administrative pharmacy : RSAP2019Senior author

DOI: 10.1016/j.sapharm.2018.11.001 PMID: 30448031

06

What are priorities for deprescribing for elderly patients? Capturing the voice of practitioners: a modified delphi process.

Farrell B, Tsang C, Raman-Wilms L, Irving H, Conklin J, Pottie K

PloS one2015

DOI: 10.1371/journal.pone.0122246 PMID: 25849568

07

5S rRNA gene arrangements in protists: a case of nonadaptive evolution.

Drouin G, Tsang C

Journal of molecular evolution2012Senior author

DOI: 10.1007/s00239-012-9512-5 PMID: 22782647

Oral Vancomycin for the Prevention of C. difficile Infection in High-Risk HCT and CAR-T Patients (VAPOR-HCT): A Pilot Randomized Placebo-Controlled Trial

Principal investigatorCIHR2025Project Grant - Priority Announcement - Cancer Survivorship

Principal investigators: MacFadden, Derek R; Atkins, Harold L; Buchan, Catharine A; Cheng, Matthew P; Climans, Troy; Coburn, Bryan A; Daneman, Nick; Gauthier, Karine; Hay, Annette; Kabbani, Dima; Kekre, Natasha; Kennah, Michael; McIntyre, Lauralyn A; Mertz, Dominik; Monteith, Bethany E; Mortimer, Leanne M; Purssell, Andrew; Taljaard, Monica; Tsang, Corey

Keywords: Antimicrobial Resistance; Biomarker; C.Difficile Infection; Chimeric Antigen Receptor T-Cell Therapy; Feasibility; Hematopoietic Stem Cell Transplantation; Microbiome; Pilot; Prophylaxis; Randomized Trial

$100,000

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Frequent collaborators

Department of Medicine
Family Medicine
C.T. Lamont Primary Health Care Research Centre (CTLC)
Other

Co-authors at University of Ottawa, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.

Barbara Farrell

Department of Medicine

2 shared papers, latest 2019

Amirrtha Srikanthan

Department of Medicine

1 shared papers, latest 2022

Douglas Archibald

Family Medicine

1 shared papers, latest 2019

Kevin Pottie

C.T. Lamont Primary Health Care Research Centre (CTLC)

1 shared papers, latest 2015

James Conklin

Faculty

1 shared papers, latest 2015

Tzu-Fei Wang

Department of Medicine

1 shared papers, latest 2025

Ayub Akbari

Department of Medicine

1 shared papers, latest 2021

Marc Carrier

Department of Medicine

1 shared papers, latest 2025

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2025

Subject: Prospective PhD student: Antimicrobial Resistance Dear Professor Tsang, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Drug-drug interactions in anticoagulant therapy: a focus on oncology patients." (2025), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Oral Vancomycin for the Prevention of C. difficile Infection in High-Risk HCT and CAR-T Patients (VAPOR-HCT): A Pilot Randomized Placebo-Controlled Trial" (2025), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]